Yi Xu
Fortuna: 3 M $ al 31/07/2026
Fortuna: 3 M $ al 31/07/2026
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Daan Gene Co., Ltd.
Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment 0,3 % | 30/09/2025 | 4.119.937 ( 0,3 % ) | 3 M $ | 31/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Harvest Fund Management Co., Ltd.
Harvest Fund Management Co., Ltd. Investment ManagersFinance HFM is an active, research-driven manager which constructs portfolio based on a combination of bottom-up and top-down fundamental research and quantitative analysis. They believe that the market is inefficient and that thorough analysis and active management can bring about excess returns. The firm has a strict quantitative risk control system for long-term, stable, and excellent performance. | Gestor de Cartera-Acciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 1 |
|---|---|
Harvest Fund Management Co., Ltd.
Harvest Fund Management Co., Ltd. Investment ManagersFinance HFM is an active, research-driven manager which constructs portfolio based on a combination of bottom-up and top-down fundamental research and quantitative analysis. They believe that the market is inefficient and that thorough analysis and active management can bring about excess returns. The firm has a strict quantitative risk control system for long-term, stable, and excellent performance. | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.